116 related articles for article (PubMed ID: 12656460)
21. Prognostic significance of invasion depth in oral tongue squamous cell carcinoma.
Tan WJ; Chia CS; Tan HK; Soo KC; Iyer NG
ORL J Otorhinolaryngol Relat Spec; 2012; 74(5):264-70. PubMed ID: 23128365
[TBL] [Abstract][Full Text] [Related]
22. Frequency of pain and correlation with clinical and histologic parameters in T1 squamous cell carcinoma of the tongue: a retrospective pilot study.
Nikitakis NG; Sarlani E; Kolokythas A; Scheper MA; Kamperos G; Ord RA; Sklavounou-Andrikopoulou A
J Oral Facial Pain Headache; 2014; 28(1):46-51. PubMed ID: 24482787
[TBL] [Abstract][Full Text] [Related]
23. TNM staging compared with a new clinicopathological model in predicting oral tongue squamous cell carcinoma survival.
Okuyemi OT; Piccirillo JF; Spitznagel E
Head Neck; 2014 Oct; 36(10):1481-9. PubMed ID: 23996811
[TBL] [Abstract][Full Text] [Related]
24. Oral squamous cell carcinoma grading systems--analysis of the best survival predictor.
Lindenblatt Rde C; Martinez GL; Silva LE; Faria PS; Camisasca DR; Lourenço Sde Q
J Oral Pathol Med; 2012 Jan; 41(1):34-9. PubMed ID: 21902722
[TBL] [Abstract][Full Text] [Related]
25. Malignancy grading is no better than conventional histopathological grading in small squamous cell carcinoma of tongue and floor of mouth: retrospective study in 128 patients.
Weijers M; Snow GB; Bezemer PD; van der Waal I
J Oral Pathol Med; 2009 Apr; 38(4):343-7. PubMed ID: 19222711
[TBL] [Abstract][Full Text] [Related]
26. Histological grading of malignancy in squamous cell carcinoma of the oral tongue.
Holm LE; Lundquist PG; Silfverswärd C; Sobin A
Acta Otolaryngol; 1982; 94(1-2):185-92. PubMed ID: 7124386
[TBL] [Abstract][Full Text] [Related]
27. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ
Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277
[TBL] [Abstract][Full Text] [Related]
28. Tumor thickness and risk of lymph node metastasis in patients with squamous cell carcinoma of the tongue.
Mücke T; Kanatas A; Ritschl LM; Koerdt S; Tannapfel A; Wolff KD; Loeffelbein D; Kesting M
Oral Oncol; 2016 Feb; 53():80-4. PubMed ID: 26625728
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological factors in early squamous cell carcinoma of the tongue and floor of the mouth, in Biscay (the Basque Country, Spain).
Martínez-Conde R; Aguirre JM; Burgos JJ; Rivera JM
Med Oral; 2001; 6(2):87-94. PubMed ID: 11500624
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors of clinically stage I and II oral tongue carcinoma-A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features.
Po Wing Yuen A; Lam KY; Lam LK; Ho CM; Wong A; Chow TL; Yuen WF; Wei WI
Head Neck; 2002 Jun; 24(6):513-20. PubMed ID: 12112547
[TBL] [Abstract][Full Text] [Related]
31. Prognostic indicators for squamous cell carcinoma of the oral cavity: a clinicopathologic correlation.
Gluckman JL; Pavelic ZP; Welkoborsky HJ; Mann W; Stambrook P; Gleich L; Wilson K; Righi P; Portugal LG; McDonald J; Biddinger P; Steward D; Gartside P
Laryngoscope; 1997 Sep; 107(9):1239-44. PubMed ID: 9292610
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of peroxiredoxin 6 and cyclophilin A in squamous cell carcinoma of the tongue.
Huang CF; Sun ZJ; Zhao YF; Chen XM; Jia J; Zhang WF
Oral Dis; 2011 Apr; 17(3):328-34. PubMed ID: 20796224
[TBL] [Abstract][Full Text] [Related]
34. Quantitative analysis of invasive front in tongue cancer using ultrasonography.
Kaneoya A; Hasegawa S; Tanaka Y; Omura K
J Oral Maxillofac Surg; 2009 Jan; 67(1):40-6. PubMed ID: 19070746
[TBL] [Abstract][Full Text] [Related]
35. Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors.
Kawasaki G; Kato Y; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Apr; 93(4):446-54. PubMed ID: 12029284
[TBL] [Abstract][Full Text] [Related]
36. The importance of lymph node ratio for locoregional recurrence of squamous cell carcinoma of the tongue.
Safi AF; Grandoch A; Nickenig HJ; Zöller JE; Kreppel M
J Craniomaxillofac Surg; 2017 Jul; 45(7):1058-1061. PubMed ID: 28529103
[TBL] [Abstract][Full Text] [Related]
37. Long term survival and impact of various prognostic factors in T1, T2 oral tongue cancer in Pakistan.
Hussain R; Jamshed A; Iqbal H; Usman S; Irfan M; Hafeez Bhatti AB
J Pak Med Assoc; 2016 Feb; 66(2):187-93. PubMed ID: 26819166
[TBL] [Abstract][Full Text] [Related]
38. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
[TBL] [Abstract][Full Text] [Related]
39. Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue.
Alves PM; Godoy GP; Gomes DQ; Medeiros AM; de Souza LB; da Silveira EJ; Vasconcelos MG; Queiroz LM
Pathol Res Pract; 2011 Apr; 207(4):236-40. PubMed ID: 21397408
[TBL] [Abstract][Full Text] [Related]
40. [Histological malignancy grading of oral squamous cell carcinomas].
Yamamoto E; Nakagawa K; Fujimoto E; Muroki T; Kumagai S; Kojima S; Takatsuka S
Gan No Rinsho; 1989 Nov; 35(14):1665-72. PubMed ID: 2593233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
